The pivotal clinical trial leading to approval of the new filler was conducted at 15 sites in North America. It included 235 patients who were treated to correct midface volume deficit and 47 untreated controls. Eligible patients had moderate, significant or severe midface volume deficit as assessed using a six-point validated rating scale.
A five-product topical regimen may provide patients with facial photodamage and hyperpigmentation with an effective, comprehensive treatment, according to study results presented at the American Academy of Dermatology Summer Meeting.
In a single-center, 24-week study, researchers assessed the efficacy and tolerance of a five-product regimen known as GRASS in 72 patients with Fitzpatrick Skin types I to IV.
The U.S. Food and Drug Administration announced that some health care providers have used an intranasal splint from Enhancement Medical as a dermal filler — an indication for which the product has not been FDA-approved.
Use of the intranasal splint, Expression, as a dermal filler has resulted in reports of adverse events, including swelling, tenderness, lumps, bumps, bruising, pain, redness, discoloration, itching and the development of hard nodules, according to a press release from the FDA.
Researchers have developed a fast and inexpensive way to make facial prostheses for eye cancer patients using facial scanning software and 3-D printing, according to findings released at AAO 2014, the 118th annual meeting of the American Academy of Ophthalmology. Their novel process can create more affordable prosthetics for any patients who have hollow sockets resulting from eye surgery following cancer or congenital deformities.
Recovery of blinking function is a critical but easily overlooked outcome after facial transplantation, according to a report in the January issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS)